Literature DB >> 15273125

1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH).

Xin He1, Anne McElwee Reeve, Umesh R Desai, Glen E Kellogg, Kevin A Reynolds.   

Abstract

The enzyme FabH catalyzes the initial step of fatty acid biosynthesis via a type II dissociated fatty acid synthase. The pivotal role of this essential enzyme, combined with its unique structural features and ubiquitous occurrence in bacteria, has made it an attractive new target for the development of antibacterial and antiparasitic compounds. We have searched the National Cancer Institute database for compounds bearing structural similarities to thiolactomycin, a natural product which exhibits a weak activity against FabH. This search has yielded several substituted 1,2-dithiole-3-ones that are potent inhibitors of FabH from both Escherichia coli (ecFabH) and Staphylococcus aureus (saFabH). The most potent inhibitor was 4,5-dichloro-1,2-dithiole-3-one, which had 50% inhibitory concentration (IC50) values of 2 microM (ecFabH) and 0.16 microM (saFabH). The corresponding 3-thione analog exhibited comparable activities. Analogs in which the 4-chloro substituent was replaced with a phenyl group were also potent inhibitors, albeit somewhat less effectively (IC50 values of 5.7 and 0.98 microM for ecFabH and saFabH, respectively). All of the 5-chlorinated inhibitors were most effective when they were preincubated with FabH in the absence of substrates. The resulting enzyme-inhibitor complex did not readily regain activity after excess inhibitor was removed, suggesting that a slow dissociation occurs. In stark contrast, a series of inhibitors in which the 5-chloro substituent was replaced with the isosteric and isoelectronic trifluoromethyl group were poorer inhibitors (IC50 values typically ranging from 25 to >100 microM for both ecFabH and saFabH), did not require a preincubation period for maximal activity, and generated an enzyme-inhibitor complex which readily dissociated. Possible modes of binding of 5-chloro-1,2-dithiole-3-ones and 5-chloro-1,2-dithiole-3-thiones with FabH which account for the role of the 5-chloro substituent were considered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273125      PMCID: PMC478545          DOI: 10.1128/AAC.48.8.3093-3102.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling.

Authors:  Robert A Daines; Israil Pendrak; Kelvin Sham; Glenn S Van Aller; Alex K Konstantinidis; John T Lonsdale; Cheryl A Janson; Xiayang Qiu; Martin Brandt; Sanjay S Khandekar; Carol Silverman; Martha S Head
Journal:  J Med Chem       Date:  2003-01-02       Impact factor: 7.446

Review 2.  Bioinformatics and the discovery of novel anti-microbial targets.

Authors:  Craig Volker; James R Brown
Journal:  Curr Drug Targets Infect Disord       Date:  2002-12

Review 3.  Fatty acid synthase, a proficient multifunctional enzyme.

Authors:  S J Wakil
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

4.  Complementation of mutations and nucleotide sequence of FAS1 gene encoding beta subunit of yeast fatty acid synthase.

Authors:  S S Chirala; M A Kuziora; D M Spector; S J Wakil
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

5.  Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12.

Authors:  J T Tsay; W Oh; T J Larson; S Jackowski; C O Rock
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

6.  Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.

Authors:  Xin He; Kevin A Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  A flexible route to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis.

Authors:  Jill M McFadden; Gojeb L Frehywot; Craig A Townsend
Journal:  Org Lett       Date:  2002-10-31       Impact factor: 6.005

8.  Thionation with the reagent combination of phosphorus pentasulfide and hexamethyldisiloxane.

Authors:  Thomas J Curphey
Journal:  J Org Chem       Date:  2002-09-06       Impact factor: 4.354

9.  Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli.

Authors:  I Nishida; A Kawaguchi; M Yamada
Journal:  J Biochem       Date:  1986-05       Impact factor: 3.387

10.  The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.

Authors:  Sean T Prigge; Xin He; Lucia Gerena; Norman C Waters; Kevin A Reynolds
Journal:  Biochemistry       Date:  2003-02-04       Impact factor: 3.162

View more
  14 in total

1.  Discovery of FabH/FabF inhibitors from natural products.

Authors:  Katherine Young; Hiranthi Jayasuriya; John G Ondeyka; Kithsiri Herath; Chaowei Zhang; Srinivas Kodali; Andrew Galgoci; Ronald Painter; Vickie Brown-Driver; Robert Yamamoto; Lynn L Silver; Yingcong Zheng; Judith I Ventura; Janet Sigmund; Sookhee Ha; Angela Basilio; Francisca Vicente; José Rubén Tormo; Fernando Pelaez; Phil Youngman; Doris Cully; John F Barrett; Dennis Schmatz; Sheo B Singh; Jun Wang
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.

Authors:  Yunierkis Pérez-Castillo; Matheus Froeyen; Miguel Angel Cabrera-Pérez; Ann Nowé
Journal:  J Comput Aided Mol Des       Date:  2011-04-23       Impact factor: 3.686

3.  Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?

Authors:  Yunierkis Pérez-Castillo; Maykel Cruz-Monteagudo; Cosmin Lazar; Jonatan Taminau; Mathy Froeyen; Miguel Angel Cabrera-Pérez; Ann Nowé
Journal:  Mol Divers       Date:  2014-03-27       Impact factor: 2.943

4.  Alteration of the fatty acid profile of Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl acyl carrier protein synthase III (FabH).

Authors:  Yongli Li; Galina Florova; Kevin A Reynolds
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

Review 5.  Mining Fatty Acid Biosynthesis for New Antimicrobials.

Authors:  Christopher D Radka; Charles O Rock
Journal:  Annu Rev Microbiol       Date:  2022-06-01       Impact factor: 16.232

Review 6.  3-Ketoacyl-ACP synthase (KAS) III homologues and their roles in natural product biosynthesis.

Authors:  Risa Nofiani; Benjamin Philmus; Yosi Nindita; Taifo Mahmud
Journal:  Medchemcomm       Date:  2019-04-29       Impact factor: 3.597

7.  Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents.

Authors:  Patricia J Lee; Jayendra B Bhonsle; Heather W Gaona; Donald P Huddler; Tiffany N Heady; Mara Kreishman-Deitrick; Apurba Bhattacharjee; William F McCalmont; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Thomas H Hudson; Jacob D Johnson; Sean T Prigge; Norman C Waters
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

8.  Design, Synthesis and Biological Evaluation of Some Triazole Schiff's Base Derivatives as Potential Antitubercular Agents.

Authors:  Asma A Sager; Zainab S Abood; Wedad M El-Amary; Salah M Bensaber; Inass A Al-Sadawe; Nouri B Ermeli; Salah B Mohamed; Mohamed Al-Forgany; Ibrahim A Mrema; Mabrouk Erhuma; Anton Hermann; Abdul M Gbaj
Journal:  Open Med Chem J       Date:  2018-04-30

9.  Structure-assisted discovery of an aminothiazole derivative as a lead molecule for inhibition of bacterial fatty-acid synthesis.

Authors:  Günter Pappenberger; Tanja Schulz-Gasch; Eric Kusznir; Francis Müller; Michael Hennig
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-11-16

10.  Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors.

Authors:  Juan Sun; Xin-Yi Wang; Peng-Cheng Lv; Hai-Liang Zhu
Journal:  Sci Rep       Date:  2015-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.